Showing results (1151-1160 of 15,775) with videos related to

Sort By:
Pageof 1,578
The Journal of Antimicrobial Chemotherapy|January 1, 1997
Antibacterial activity of T-5575, a novel 2-carboxypenam, and its stability to beta-lactamaseN Matsumura, S Minami, S Mitsuhashi
The Journal of Antimicrobial Chemotherapy|January 1, 1997
In-vitro pharmacodynamic studies of piperacillin/tazobactam with gentamicin and ciprofloxacinI M Gould, K Milne
The Journal of Antimicrobial Chemotherapy|January 1, 1997
In-vitro killing activity of combinations of beta-lactam agents with aminoglycosides against penicillin-resistant pneumococciL Schlegel, G Sissia, A Fremaux, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 1996
Itraconazole for prophylaxis of systemic mycoses in neutropenic patients with haematological malignanciesA Böhme, G Just-Nübling, L Bergmann, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 1996
A comparative analysis of pharmacokinetics of ceftriaxone in serum and pleural fluid in humans: a study of once daily administration by intramuscular and intravenous routesA K Goonetilleke, D Dev, I Aziz, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 1996
Potential effects of amoxycillin/clavulanic acid and ticarcillin/clavulanic acid on human granulocyte activity: a comparative studyA M Cuffini, V Tullio, G Paizis, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 1996
In-vitro bactericidal activity of cefpirome in combination with vancomycin against Staphylococcus aureus and coagulase-negative staphylococciJ Raymond, G Vedel, M Bergeret
The Journal of Antimicrobial Chemotherapy|October 1, 1994
Susceptibility in cell culture of feline immunodeficiency virus to eighteen antiviral agentsN R Smyth, C McCracken, R M Gaskell, et al.
The Journal of Antimicrobial Chemotherapy|June 1, 1995
Defining conditions for microbroth antifungal susceptibility tests: influence of RPMI and RPMI-2% glucose on the selection of endpoint criteriaJ L Rodriguez-Tudela, J V Martinez-Suárez
The Journal of Antimicrobial Chemotherapy|June 1, 1995
In-vitro and in-vivo activities of roxithromycin in combination with pyrimethamine or sulphadiazine against Toxoplasma gondiiS Romand, A Bryskier, M Moutot, et al.
Pageof 1,578